Table 2.

Estimated cardiovascular risk and measures of subclinical atherosclerosis according to presence or absence of coronary artery disease.

Parameter	No CAD (n = 117)	Non-critical CAD (n = 47)	CAD (n = 30)	p Value
Framingham risk score (n = 192)
•Mean score ± std dev	13.0 ± 9.4	17.7 ± 10.1	20.0 ± 9.5	<0.001
•Patients with ≥20% 10-year risk, n (%)	23/117 (19.7)	17/46 (37.0)	12/29 (41.4)	0.014
JBS3 risk score (n = 191)
•Mean score ± std dev	12.2 ± 11.2	18.3 ± 12.5	24.3 ± 13.7	<0.001
•Patients with ≥20% 10-year risk, n (%)	23/116 (19.8)	14/46 (30.4)	17/29 (58.6)	<0.001
ACC/AHA risk score (n = 157)
•Mean score ± std dev	7.8 ± 7.7	11.7 ± 10.9	12.1 ± 7.7	0.02
•Patients with ≥20% 10-year risk, n (%)	7/86 (8.1)	7/43 (16.3)	6/28 (21.4)	0.13
WHO/ISH risk score (n = 157)
•Patients with ≥20% 10-year risk, n (%)	11/86 (12.8)	6/43 (14.0)	5/28 (17.9)	0.80
Carotid intima-media thickness (mm)
•Median (interquartile range)	0.60 (0.5, 0.79)	0.75 (0.60, 0.80)	0.75 (0.65, 0.90)	0.004
Coronary calcium score
•Median (interquartile range)	0 (0, 0)	18.1 (1.0, 63.2)	67.1 (21.2, 268.5)	<0.001
•Calcium score categories-
‘0’ score, n (%)	93 (79.5)	10 (21.3)	5 (16.7)
1–99, n (%)	23 (19.7)	31 (66.0)	12 (40.0)	<0.001
100–399, n (%)	1 (0.9)	5 (10.6)	9 (30.0)
≥400, n (%)	0 (0)	1 (2.1)	4 (13.3)

ACC, American College of Cardiology; AHA, American Heart Association; CAD, coronary artery disease; JBS3, 3rd iteration of the Joint British Societies.